Evidence map›Paper›PMID 36597404›Full record

ArticleInternational journal of methods in psychiatric research2023

Clinically significant anxiety as a risk factor for Alzheimer's disease: Results from a 10-year follow-up community study.

Patricia Gracia-García, Juan Bueno-Notivol, Darren M Lipnicki, Concepción de la Cámara, Antonio Lobo, Javier Santabárbara

Abstract read
In one paragraph

Article in International journal of methods in psychiatric research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Risk of Parkinson's disease in people aged ≥50 years with new-onset anxiety: a retrospective cohort study in UK primary care.The British journal of general practice : the journal of the Royal College of General Practitioners · 2024
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Patricia Gracia-GarcíaInstituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.ORCID 0000-0001-9822-6312
Juan Bueno-NotivolPsychiatry Service, Hospital Universitario Miguel Servet, Zaragoza, Spain.ORCID 0000-0002-0519-4962
Darren M LipnickiCentre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales Medicine, Randwick, Australia.
Concepción de la CámaraInstituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.
Antonio LoboInstituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.ORCID 0000-0002-9098-655X
Javier SantabárbaraInstituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThere is growing evidence for an association between anxiety and an increased risk of dementia, but it is not clear whether anxiety is a risk factor or a prodromic symptom. In this study, we investigated if clinically significant anxiety increases the risk of developing Alzheimer's disease (AD) up to 10 years later.

methodsWe used data from the longitudinal Zaragoza Dementia and Depression (ZARADEMP) Project. Excluding subjects with dementia at baseline left us with 3044 individuals aged >65 years. The Geriatric Mental State-Automated Geriatric Examination for Computer Assisted Taxonomy (GMS-AGECAT) package was used to identify cases and subcases of anxiety. AD was diagnosed by a panel of research psychiatrists according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) criteria. Multivariate survival analysis with a competing risk regression model was performed.

resultsWe observed a significant association between clinically significant anxiety at baseline and AD risk within a 10-year follow-up (SHR 2.82 [95% CI 1.21-6.58]), after controlling for confounders including depression. In contrast, isolated symptoms of anxiety were not significantly associated with an increased incidence of AD.

conclusionOur results support the hypothesis that clinically significant anxiety is an independent risk factor for AD and not just a prodromic symptom. Future studies should clarify if treating anxiety reduces the incidence of AD.

Indexed as

Alzheimer DiseaseAgedAnxietyAnxiety DisordersFollow-Up StudiesHumansRisk FactorsAlzheimer's diseasecompeting riskrisk factorZARADEMP

Identifiers

PMID36597404
PMCPMC10485344

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.